Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Uptake of the Antifungal Miconazole and Effect on Estrogen Metabolizing Enzymes in Humans

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00668538
Recruitment Status : Completed
First Posted : April 29, 2008
Last Update Posted : October 17, 2008
Odense University Hospital
Information provided by:
University of Southern Denmark

Brief Summary:
The purpose of this study, is to study the uptake of the pharmaceutical antifungal miconazole when used as a vaginal suppository in young women. The investigators want to know if the uptake is big enough to cause a biological effect (effect on CYP1A2 and CYP3A4 activity).

Condition or disease Intervention/treatment Phase
Healthy Drug: Brentan (miconazole) Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 20 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: Uptake of the Antifungal Miconazole and Effect on Estrogen Metabolizing Enzymes in Humans
Study Start Date : April 2008
Actual Primary Completion Date : August 2008
Actual Study Completion Date : August 2008

Resource links provided by the National Library of Medicine

Intervention Details:
  • Drug: Brentan (miconazole)
    Vaginal suppository 1200 mg at day 6
    Other Name: miconazole

Primary Outcome Measures :
  1. CYP1A2 and CYP3A4 activity measured as metabolite ratios of caffeine and quinidine, respectively [ Time Frame: urine and blood collected day 4 and 8 ]

Secondary Outcome Measures :
  1. Detection of miconazole or metabolites in blood and urine [ Time Frame: Blood and urine collected day 8 ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Woman
  • Age 18-45 years
  • Healthy
  • Signed consent
  • Written authority to the GCP-unit

Exclusion Criteria:

  • Pregnancy
  • Breast-feeding
  • Hypersensitivity to miconazole
  • Hypersensitivity to sodium ethyl parahydroxybenzoic acid(E219)
  • Hypersensitivity to sodium propyl parahydroxybenzoic acid (E217)
  • Using contraceptives with hormones
  • Daily consumption of alcohol
  • Daily use of medicine
  • Participated in a clinical trial within the last 3 months

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00668538

Layout table for location information
Institute of Public Health, Clinical Pharmacology, University of Southern Denmark
Odense, Denmark, 5000 C
Sponsors and Collaborators
University of Southern Denmark
Odense University Hospital
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Professor, M.D. Kim Brosen, University of Southern Denmark Identifier: NCT00668538    
Other Study ID Numbers: AKF-373
EudraCT 2008-000796-17
First Posted: April 29, 2008    Key Record Dates
Last Update Posted: October 17, 2008
Last Verified: October 2008
Keywords provided by University of Southern Denmark:
Healthy Subjects
Additional relevant MeSH terms:
Layout table for MeSH terms
Antifungal Agents
Anti-Infective Agents
14-alpha Demethylase Inhibitors
Cytochrome P-450 Enzyme Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Steroid Synthesis Inhibitors
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs
Cytochrome P-450 CYP2C9 Inhibitors
Cytochrome P-450 CYP3A Inhibitors
Anti-Infective Agents, Local